In general, guidance and research suggest: Approved medications are often considered when patients havent achieved meaningful weight loss with lifestyle interventions
A meta-analysis of 12 randomized controlled trials found berberine produced approximately 4.5 pounds of weight loss on average, significantly less than prescription GLP-1s but more than placebo
They offer a personalized approach to building healthy habits
Who Qualifies GLP-1 medications for weight management are appropriate for adults who meet the following criteria: BMI of 30 or higher (obesity), or BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea) Who should not take GLP-1 medications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis Severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Pregnancy or planning to become pregnant Known hypersensitivity to semaglutide, tirzepatide, or any component of the formulation Your physician will review your full medical history, screen for contraindications, and assess your relationship with food and body image before prescribing
Attorneys for Novo Nordisk, Ozempics manufacturer, want each plaintiff to have had a stomach emptying test to diagnose the disorder